Treatments for post-vaccine blood clots show promise but no ‘slam dunk,’ Canadian doctor …


Sumary of Treatments for post-vaccine blood clots show promise but no ‘slam dunk,’ Canadian doctors say:

  • Ever since health officials announced Canada’s first known case of rare, post-vaccination blood clots back in April, scientists have been racing to learn more about what causes the potentially deadly condition — and how to treat it..
  • The potential effectiveness was outlined in three case studies featuring some of the first Canadian patients who developed post-vaccine blood clots, which was published Wednesday in The New England Journal of Medicine..
  • The three patients between the ages of 63 and 72 were all given a dose of the AstraZeneca-Oxford COVID-19 vaccine, the paper states, and were later diagnosed with vaccine-induced immune thrombotic thrombocytopenia (VITT)..
  • Two developed clotting in their legs, including one who later required amputation, and the third suffered from blocked arteries and veins inside their brain..
  • Ishac Nazy is one of the researchers behind a new paper focused on treatments for post-vaccine blood clots, and the scientific director of the McMaster Platelet Immunology Laboratory..
  • Here, he explains how intravenous immunoglobulin, or IVIG, works to treat patients suffering from these rare, but potentially-deadly, clots..
  • 0:43 “What we recognized early on is that all three patients were treated with anticoagulants [or anti-clotting medication] along with intravenous immunoglobulin, or IVIG,”.
  • IVIG is a treatment made up of antibodies that can be given intravenously, and it’s long been used to help treat autoimmune conditions….

Want to know more click here go to source.

From -
Generic selectors
Exact matches only
Search in title
Search in content

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.